Fuda Cancer Hospital
Bone cancer treatment cost in China typically ranges from $9,500 to $22,500 for bone resection and approximately Price on request to Price on request for reconstruction with implant replacement. Total expenses depend on tumor complexity, reconstruction materials, and clinic tier. Patients often achieve 60% to 80% savings compared to the United States. Top treatment hubs include Guangzhou, Xiamen, and Beijing.
Typical Bone Cancer Treatment Costs in China
Bookimed Expert Insight: Patients with late-stage bone cancer benefit from advanced technologies like cryosurgery or NanoKnife at JCI-accredited facilities. Fuda Cancer Hospital specializes in these minimally invasive approaches for complex cases. For those requiring precise radiation, multidisciplinary centers in Xiamen offer expertise in IMRT and SBRT. These tertiary hospitals utilize clinical trials to provide access to emerging therapies efficiently.
| China | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $11,500 | from $7,000 | from $12,000 |
| Chemotherapy for breast cancer | from $14,800 | from $1,200 | from $15,000 |
| Bone resection | from $9,500 | from $8,000 | from $25,000 |
| Bone deformity correction surgery | from $13,500 | from $2,500 | from $30,000 |
| Actinium-225 Therapy | from $13,800 | from $22,955 | from $55,000 |
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
The doctor is a renowned expert in minimally invasive cryosurgery for cancer, serving as President and chief surgeon at Fuda Cancer Hospital since 2001. With a focus on oncology and minimally invasive procedures, the doctor has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures, treating patients aged 4 to 94.
Graduating from The Fourth Military Medical University with a specialty in thoracic and cardiac surgery, the doctor has contributed significantly to the field with over 100 published papers. Recognized with awards for outstanding contributions to cryosurgery, the doctor holds vice-presidential roles in both the Asian and International Societies of Cryosurgery.
Medical treatment for bone cancer in China centers on multidisciplinary protocols. These include limb-salvage surgery, advanced 3D-printed reconstructions, and specialized chemotherapy. JCI-accredited centers also utilize minimally invasive options like cryosurgery and NanoKnife. Integrated traditional Chinese medicine helps manage symptoms and treatment side effects.
Bookimed Expert Insight: China offers a unique advantage for patients seeking alternatives to traditional chemotherapy through hospitals like Fuda. This facility has treated over 30,000 international patients by applying over 10 types of minimally invasive therapies. These options target late-stage cancers while potentially reducing the systemic burden on the patient.
Patient Consensus: Patients emphasize the importance of early expert consultation to maximize chances for limb-sparing surgery. Practical concerns often focus on the logistical burden of traveling to major urban centers and coordinating extensive rehabilitation.
China provides advanced minimally invasive bone cancer treatments through JCI-accredited facilities. Specialized centers utilize localized needle-based ablation and targeted vascular therapies. These technologies aim to destroy tumors while preserving bone structure. Precision radiotherapy and cell therapies address complex primary or metastatic cases.
Bookimed Expert Insight: Data from Fuda Cancer Hospital shows a preference for combining multiple minimally invasive therapies. They often use cryosurgery and vascular intervention instead of traditional chemotherapy. This approach serves a high volume of over 30,000 international patients. It is particularly effective for late-stage patients seeking to maintain quality of life.
Patient Consensus: Patients note that modern limb-sparing surgery is a major alternative to amputation. They emphasize having a biopsy plan created by the same team that performs surgery.
Traditional Chinese Medicine (TCM) serves as a supportive therapy in Chinese bone cancer care. It focuses on pain relief and managing chemotherapy side effects. Facilities like Xiamen Humanity Hospital integrate these modalities alongside precision radiotherapy. TCM never replaces surgery or essential oncology protocols.
Bookimed Expert Insight: Chinese oncology centers often combine specialized TCM rehabilitation with high-tech interventions. For instance, Xiamen Humanity Hospital employs over 460 doctors and manages 1,000,000 patients annually. This massive scale allows for highly specialized integrative departments. These units focus specifically on balancing systemic wellness with advanced technologies like IMRT and VMAT.
Patient Consensus: Patients emphasize using TCM to feel stronger and improve digestion rather than targeting the tumor. They note that informing the oncology team about every herb is vital to avoid drug interactions.
China offers specialized bone cancer care at JCI-accredited oncology centers and large tertiary hospitals. Facilities in Guangzhou and Xiamen provide advanced treatments like NanoKnife and cryosurgery. These centers maintain dedicated international departments to support foreign patients with translation, visa logistics, and multidisciplinary treatment planning.
Bookimed Expert Insight: Xiamen Humanity Hospital stands out for its massive scale. It manages 1,000,000 patients annually and has 46 clinical departments. This high volume often translates to significant expertise in handling rare drug trials. Patients seeking unique interventions may find these clinical trial-level capabilities highly beneficial compared to standard oncology centers.
Patient Consensus: Patients emphasize the importance of having biopsy slides re-read by expert pathologists at high-volume sarcoma centers. They note that specialized support and English-speaking coordination are as vital as the surgery for a smooth recovery.
Chinese hospitals coordinate bone cancer work-ups through a centralized Multidisciplinary Team (MDT) framework. This protocol integrates orthopedic surgery, oncology, and radiology at Class 3 Grade A centers. These hubs follow national clinical pathways to ensure diagnostic imaging and biopsy align with future surgical goals.
Bookimed Expert Insight: Clinical volume significantly impacts diagnostic speed in China. Xiamen Humanity Hospital serves approximately 1,000,000 patients annually across 47 departments. This high volume allows tertiary centers to stabilize diagnostic timelines. These facilities often offer advanced precision radiotherapy like IMRT or VMAT. Choosing a high-capacity center ensures your radiology and pathology reviews are batched efficiently.
Patient Consensus: Patients note it is essential to bring original imaging disks rather than just printed reports. They emphasize that the biopsy must be performed at the same hospital where the final surgery occurs.
Chinese oncology centers provide integrated logistical workflows to support overseas bone cancer patients during complex treatments. Facilities like Fuda Cancer Hospital utilize dedicated international departments to manage medical visas, airport transfers, and 24/7 multilingual translation. These services streamline navigation through large-scale medical campuses in major cities.
Bookimed Expert Insight: Quality signals in China often correlate with high patient volumes and international accreditations. For instance, Xiamen Humanity Hospital serves approximately 1,000,000 patients annually. Meanwhile, Fuda Cancer Hospital maintains JCI accreditation while treating people from over 100 countries. Choosing a JCI-accredited facility ensures that logistical protocols meet global safety and communication standards.
Patient Consensus: Patients note that while hospitals are highly efficient at processing diagnostic tests, families are often expected to help with daily tasks. Having a dedicated international coordinator is essential for navigating payment systems and large hospital buildings.